tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Compare Editas Medicine (EDIT) vs. Competitors

Compare
3,557 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$2.46
$240.77M
-1.14
74.47%
3 Buy
3 Hold
2 Sell
Hold
Cellectis SA
$3.45
$260.24M
121.36
181.63%
1 Buy
1 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$5.06
$297.02M
-4.58
10.00%
7 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$12.18
$224.06M
-3.95
54.18%
3 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$13.72
$569.65M
-0.10
-20.26%
2 Buy
0 Hold
0 Sell
Moderate Buy
Caribou Biosciences
$1.97
$190.38M
-1.42
93.14%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.46
1.15
87.07%
CLLS
Cellectis SA
3.45
2.18
171.65%
FHTX
Foghorn Therapeutics
5.06
0.62
13.96%
ELTX
Elicio Therapeutics
12.18
4.21
52.82%
VOR
Vor Biopharma
13.72
-2.81
-17.00%
CRBU
Caribou Biosciences
1.97
1.02
107.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts